MOGAD
Signs & Symptoms
MOG antibody disease preferentially causes inflammation in the optic nerve,14 but can also cause inflammation in the spinal cord, brain, and brainstem.15 The recent diagnostic criteria for MOG antibody disease include the following clinical inflammatory attacks:4
- Optic neuritis (inflammation in the optic nerve), which results in vision loss in one or both eyes (often both eyes in MOGAD)
- Transverse myelitis (inflammation in the spinal cord), which often causes arm or leg weakness, changes in how things feel, and bowel, bladder, or sexual issues
- Acute disseminated encephalomyelitis (ADEM) (inflammation in the brain and spinal cord, often in children), which can result in seizures, changes in behavior, mood, or thinking, and changes or loss of function in certain areas of the body
- Cerebral monofocal or polyfocal deficits (inflammation in one or more areas of the brain), which can cause different symptoms such as vision problems, difficulty speaking, changes in how things feel, balance problems, and weakness in the face, arms, or legs
- Brainstem or cerebellar deficits (inflammation in the back or bottom of the brain), which often includes double vision or issues with balance and coordination
- Cerebral cortical encephalitis (inflammation in the outer layer of the brain), which often causes seizures, changes in thinking or behavior, stroke-like episodes, headache, or fever
MOG antibody disease can also rarely occur in relation to another condition called anti-N-methyl-D-aspartate (NMDA) receptor encephalitis.1 NMDA receptor encephalitis is an autoimmune encephalitis that can cause psychosis, issues with memory and language, and seizures.1
(1) Fan S, Xu Y, Ren H, et al. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis. Mult Scler Relat Disord. 2018 Feb;20:144-152. doi: 10.1016/j.msard.2018.01.007. Epub 2018 Jan 31.
(4) Banwell B, Bennett JL, Marignier R, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023 Mar;22(3):268-282. doi: 10.1016/S1474-4422(22)00431-8. Epub 2023 Jan 24.
(14) Cobo-Calvo A, Ruiz A, Maillart E, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology. 2018 May 22;90(21):e1858-e1869. doi: 10.1212/WNL.0000000000005560. Epub 2018 Apr 25.
(15) Lechner C, Baumann M, Hennes EM, et al. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):897-905. doi: 10.1136/jnnp-2015-311743. Epub 2015 Dec 8.